Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

The Latest Breaking News from Vaccine

COVID vaccine rates plummet but antiviral use up, as COVID cases rise

'Still a lot of COVID around' and 36 in hospital in district.

Newcastle Herald

As JN.1 emerges as variant of interest, time to evaluate preparedness and effective testing and treatments

WHO classifies JN.1 as a separate variant of interest (VOI) with potential to affect virus characteristics & increase burden of respiratory infections. Vaccines expected to increase protection against JN.1. India detects 21 cases, all mild.

The Hindu

WHO prequalifies a second malaria vaccine manufactured by Serum Institute of India

WHO prequalifies R21/Matrix-M malaria vaccine to increase access & prevent malaria in children.

The Hindu

From analysis to the latest developments in health,
read the most diverse news in one place.

Doctors fear NHS could buckle in flu season as staff avoid vaccine

Exclusive: Less than 40 per cent of frontline staff were vaccinated ahead of winter, risking staff shortages and flu transmission

The Independent UK

Second malaria vaccine prequalified by WHO: Know what this means

The World Health Organisation (WHO) has added the second malaria vaccine to its list of prequalified vaccines. The vaccine, R21/ Matrix-M malaria vaccine, was recommended by the WHO for malaria treatment in October 2023. The R21 vaccine is the second malaria vaccine prequalified by the WHO, following the RTS, S/AS01…

The Times of India

JN.1: What to know about the new Covid variant surging in the US

Infectious disease experts say the best way to protect yourself from the JN.1 subvariant is to get the updated Covid 19 vaccine

The Independent UK

Pfizer Sues Poland And Hungary Over Covid Debts

Pharmaceutical firms Pfizer and BioNTech are suing the governments of Poland and Hungary alleging they failed to pay for vaccines ordered during the Covid pandemic, lawyers said Tuesday.

International Business Times

Read news from The Economist, FT, and more,
with one subscription

Victorian Britain had its own anti-vaxxers – and they helped bring down a government

As the 1906 UK general election results rolled in, it became clear that the Conservative party, after 11 years in power, had suffered one of the most disastrous defeats in its history. Of 402 Conservative MPs, 251 lost their seats, including their candidate for prime minister, defeated on a 22.5%…

The Conversation

mRNA COVID vaccines make 'unintended proteins' – we've discovered how to fix this problem

MRNA, a type of genetic material that provides the instructions your cells need in order to make proteins, used to be a term mainly used by scientists. But since COVID arrived many of us are now familiar with it thanks to the mRNA-based vaccines.

The Conversation

mRNA, easy to customise, is the next frontier for personalised medicine

Because it is so easy to change the mRNA recipes, cancer vaccines can be part of a personalized medicine plan where doctors sample a patient’s tumour, sequence key genes and adjust the mRNA treatment to include recipes specific to that patient’s cancer. Clinical trials using this personalized approach for pancreatic…

The Hindu

Get Your Shots Immediately: CDC Warns Of 'Urgent Need' To Boost Vaccine Coverage As Respiratory Illnesses Surge

Low vaccination rates against influenza, COVID-19 and RSV, along with an increase in respiratory diseases, could pose a potential strain on the healthcare system, the CDC warned.

Medical Daily

Moderna CEO Says Melanoma Vaccine Could Be Available By 2025

Globally there were an estimated 325,000 new melanoma cases and 57 ,000 deaths from the disease in 2020.

Latin Times

Moderna Tests Promising Personalized Skin Cancer Vaccine with 49% Improvement!

Moderna tests a novel approach to battle skin cancer, with a vaccine showing benefits for melanoma patients. Treatment could be available by 2025.

Top News

Moderna CEO Says Melanoma Vaccine Could Be Available By 2025

Moderna CEO Stephane Bancel told AFP his company's experimental vaccine against melanoma could be available in as little as two years, in what would amount to a landmark step against the most serious form of skin cancer.

International Business Times

Get all your
news in one place.

100's of premium titles.
One news app.

The Conversation

CRISPR and other new technologies open doors for drug development, but which diseases get prioritized? It comes down to money and science

Prescription drugs and vaccines revolutionized health care, dramatically decreasing death from disease and improving quality of life across the globe. But how do researchers, universities and hospitals, and the pharmaceutical industry decide which diseases to pursue developing drugs for?

The Hindu

Special vaccination camp launched for children

Health Dept launches special camp in Chennai to provide Measles-Rubella vaccine to 27.42 lakh children aged 9 months-15 years in cyclone-hit districts. 10 lakh doses sought from Union govt. 6,421 camps organised, 4.69 lakh persons benefited, 6,403 with fever, 71,561 with cough/cold.

The Conversation

Health misinformation is rampant on social media – here's what it does, why it spreads and what people can do about it

The global anti-vaccine movement and vaccine hesitancy that accelerated during the COVID-19 pandemic show no signs of abating.

AAP

COVID-19 pandemic response continues to press on budget

Continuing to pay for COVID-19 vaccines and treatments will cost Australians hundreds of millions of dollars, with the threat posed by the virus far from over.

Get all your
news in one place.

100's of premium titles.
One news app.

Chicago Sun-Times

There’s more work to do to close the racial gap in COVID-19, flu vaccination

The Urban League and other groups worked hard during the pandemic to raise vaccination rates among Black Americans. The gap is smaller, but Blacks are still less likely than whites to receive COVID-19 and influenza vaccines.

The Guardian - UK

AstraZeneca buys US vaccine company in $1.1bn deal

Britain’s biggest drugmaker acquires Seattle-based firm Icosavax, expanding vaccine and immune therapy business

International Business Times UK

UKHSA Highlights Disparities in Flu and COVID-19 Hospital Admissions

UK Health Security Agency (UKHSA) has issued a strong call to action, urging eligible individuals, especially those from ethnic minority groups, to book their flu and COVID-19 vaccines.

International Business Times UK

Africa Trials for HIV Vaccine Discontinued as Initial Results Disappoint

The African-led trial was initiated in December 2020 but came to an early halt last month. Its conclusive findings are to be released in 2024.

The Conversation

Whooping cough cases increasing in the UK – what you need to know

You may have read recent alarming reports of a cough that “lasts 100 days” is “quickly spreading across the UK” and can “fracture ribs”. If you didn’t look beyond the headlines, you might have missed the fact that the reports are about whooping cough.

AAP

New COVID-19 vaccines hit pharmacy shelves

Two new COVID-19 vaccines targeting the new Omicron variant of the virus are now available in Australian pharmacies around the nation.

The Hindu

Over 1.32 lakh persons screened at camps in Tamil Nadu

Special medical camps held in cyclone-affected districts of TN screen 1.3L; MR vaccine advised for children in flood-hit areas. Health Minister launched camps in 679 places, 200 each in Tiruvallur & Chengalpattu, 100 in Kancheepuram. Screening for dengue, chikungunya, diarrhoea, sore throat & cough; MR vaccine advised for children in…

1 … 104 105 106 107

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

the World Health Organization

the Centers for Disease Control and Prevention

217 stories

BioNTech

203 stories

the World Health Organisation

193 stories

The National Institutes of Health

152 stories

Health Security Agency

27 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.